CD80 plays an important role in T-cell activation, exerting a dual effect on tumor immunity: it binds to CD28 to provide a costimulatory signal for T-cell activation, and it binds to CTLA-4, resulting in an immunosuppressive effect. The gene discussed is CTLA4; the disease is neoplasm.